Background It is expected that GPs are increasingly confronted with a large group of patients
with symptoms persisting three weeks after initial symptoms of a mild (managed in the …

Whilst the entire world is battling the second wave of COVID-19, a substantial proportion of
patients who have suffered from the condition in the past months are reporting symptoms …

Objectives/Hypothesis Olfactory dysfunction has been observed as one of the clinical
manifestations in COVID‐19 patients. We aimed to conduct a systematic review and meta …

A significant proportion of people who test positive for COVID-19 have chemosensory
deficits. However, the reported prevalence of these deficits in smell and taste varies widely …

Background: Olfactory training is the only evidence-based treatment for post-viral olfactory
dysfunction. Smell disorders after SARS-CoV-2 infection have been attributed to …

Background: The present study aimed to determine the global prevalence of anosmia and
dysgeusia in coronavirus disease 2019 (COVID-19) patients and to assess their association …

Survivors to COVID-19 have described long-term symptoms after acute disease. These
signs constitute a heterogeneous group named long COVID or persistent COVID. The aim of …

Objective We characterized the evolution of neurologic symptoms and self‐perceived
recovery of non‐hospitalized COVID‐19 “long haulers” 6–9 months after their initial Neuro …

Background The presence of olfactory dysfunction or “loss of smell” has been reported as an
atypical symptom in patients with coronavirus disease 2019 (COVID-19). We performed a …

Smell alteration and cognitive impairment are common features of the Long-COVID
Syndrome. Mental clouding, often described as brain fog, might affect smell by altering …